Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

The antiphospholipid syndrome (APS) is characterized by the development of venous and/or arterial thrombosis and pregnancy morbidity in patients with persistent antiphospholipid antibodies (aPL). Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening form of APS occurring in about 1% of...

Full description

Bibliographic Details
Main Authors: Ilaria Mormile, Francescopaolo Granata, Alessandra Punziano, Amato de Paulis, Francesca Wanda Rossi
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biomedicines
Subjects:
antiphospholipid syndrome
lupus anticoagulant
anticardiolipin
anti-β2-glycoprotein I
catastrophic antiphospholipid syndrome
Online Access:https://www.mdpi.com/2227-9059/9/2/132

Internet

https://www.mdpi.com/2227-9059/9/2/132

Similar Items